Parapharyngeal Ganglioneuroma Detected by 18 F-FDG PET/CT in a Patient with Hodgkin Lymphoma

Wan Ling Yi, Tzu Pai Chen, Nan-Tsing Chiu, Ching-Hsun Liu, Yu Hsuan Lin

Research output: Contribution to journalArticle

Abstract

A 38-year-old woman with anterior mediastinal Hodgkin lymphoma underwent 18 F-FDG PET/CT, revealing abnormal uptake at the left retrostyloid parapharyngeal space. After chemotherapy, follow-up PET/CT showed regression of previously avid lesions but not the left retropharyngeal mass. Subsequent MRI revealed findings suggestive of neurogenic tumor. Transoral biopsy revealed ganglioneuroma, which is uncommon in the parapharyngeal space, although usually of benign nature. This case therefore highlights the importance of PET/CT in both initial diagnostic screening for tumor development and posttreatment evaluation of ambiguous lesions.

Original languageEnglish
Pages (from-to)240-243
Number of pages4
JournalClinical Nuclear Medicine
Volume44
Issue number3
DOIs
Publication statusPublished - 2019 Mar 1

Fingerprint

Ganglioneuroma
Hodgkin Disease
Neoplasms
Biopsy
Drug Therapy

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging

Cite this

@article{01276b9162cb4cf6b590aaac7cef723d,
title = "Parapharyngeal Ganglioneuroma Detected by 18 F-FDG PET/CT in a Patient with Hodgkin Lymphoma",
abstract = "A 38-year-old woman with anterior mediastinal Hodgkin lymphoma underwent 18 F-FDG PET/CT, revealing abnormal uptake at the left retrostyloid parapharyngeal space. After chemotherapy, follow-up PET/CT showed regression of previously avid lesions but not the left retropharyngeal mass. Subsequent MRI revealed findings suggestive of neurogenic tumor. Transoral biopsy revealed ganglioneuroma, which is uncommon in the parapharyngeal space, although usually of benign nature. This case therefore highlights the importance of PET/CT in both initial diagnostic screening for tumor development and posttreatment evaluation of ambiguous lesions.",
author = "Yi, {Wan Ling} and Chen, {Tzu Pai} and Nan-Tsing Chiu and Ching-Hsun Liu and Lin, {Yu Hsuan}",
year = "2019",
month = "3",
day = "1",
doi = "10.1097/RLU.0000000000002444",
language = "English",
volume = "44",
pages = "240--243",
journal = "Clinical Nuclear Medicine",
issn = "0363-9762",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

Parapharyngeal Ganglioneuroma Detected by 18 F-FDG PET/CT in a Patient with Hodgkin Lymphoma . / Yi, Wan Ling; Chen, Tzu Pai; Chiu, Nan-Tsing; Liu, Ching-Hsun; Lin, Yu Hsuan.

In: Clinical Nuclear Medicine, Vol. 44, No. 3, 01.03.2019, p. 240-243.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Parapharyngeal Ganglioneuroma Detected by 18 F-FDG PET/CT in a Patient with Hodgkin Lymphoma

AU - Yi, Wan Ling

AU - Chen, Tzu Pai

AU - Chiu, Nan-Tsing

AU - Liu, Ching-Hsun

AU - Lin, Yu Hsuan

PY - 2019/3/1

Y1 - 2019/3/1

N2 - A 38-year-old woman with anterior mediastinal Hodgkin lymphoma underwent 18 F-FDG PET/CT, revealing abnormal uptake at the left retrostyloid parapharyngeal space. After chemotherapy, follow-up PET/CT showed regression of previously avid lesions but not the left retropharyngeal mass. Subsequent MRI revealed findings suggestive of neurogenic tumor. Transoral biopsy revealed ganglioneuroma, which is uncommon in the parapharyngeal space, although usually of benign nature. This case therefore highlights the importance of PET/CT in both initial diagnostic screening for tumor development and posttreatment evaluation of ambiguous lesions.

AB - A 38-year-old woman with anterior mediastinal Hodgkin lymphoma underwent 18 F-FDG PET/CT, revealing abnormal uptake at the left retrostyloid parapharyngeal space. After chemotherapy, follow-up PET/CT showed regression of previously avid lesions but not the left retropharyngeal mass. Subsequent MRI revealed findings suggestive of neurogenic tumor. Transoral biopsy revealed ganglioneuroma, which is uncommon in the parapharyngeal space, although usually of benign nature. This case therefore highlights the importance of PET/CT in both initial diagnostic screening for tumor development and posttreatment evaluation of ambiguous lesions.

UR - http://www.scopus.com/inward/record.url?scp=85060908573&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060908573&partnerID=8YFLogxK

U2 - 10.1097/RLU.0000000000002444

DO - 10.1097/RLU.0000000000002444

M3 - Article

C2 - 30672755

AN - SCOPUS:85060908573

VL - 44

SP - 240

EP - 243

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

SN - 0363-9762

IS - 3

ER -